News / Events

Recent News View All News

Adial Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update

November 14, 2022

Adial Pharmaceuticals Announces Positive In Vivo Data for Purnovate’s PNV-5030 as a Potential Treatment for Chronic Pain

September 26, 2022

Recent Events View IR Calendar

2022 Annual Meeting of Stockholders

October 13, 2022 • 9:00am EST

View IR Calendar

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings